These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 37377968)

  • 21. Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies.
    Luci C; Bourinet M; Leclère PS; Anty R; Gual P
    Front Endocrinol (Lausanne); 2020; 11():597648. PubMed ID: 33384662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.
    Katsarou A; Moustakas II; Pyrina I; Lembessis P; Koutsilieris M; Chatzigeorgiou A
    World J Gastroenterol; 2020 May; 26(17):1993-2011. PubMed ID: 32536770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice.
    Dong B; Zhou Y; Wang W; Scott J; Kim K; Sun Z; Guo Q; Lu Y; Gonzales NM; Wu H; Hartig SM; York RB; Yang F; Moore DD
    Hepatology; 2020 May; 71(5):1559-1574. PubMed ID: 31506976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease.
    Asanuma T; Ono M; Kubota K; Hirose A; Hayashi Y; Saibara T; Inanami O; Ogawa Y; Enzan H; Onishi S; Kuwabara M; Oben JA
    Gut; 2010 Feb; 59(2):258-66. PubMed ID: 19919948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
    Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
    Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis.
    Peters KM; Wilson RB; Borradaile NM
    Curr Opin Lipidol; 2018 Oct; 29(5):417-422. PubMed ID: 30015675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Cha JY; Kim DH; Chun KH
    Lab Anim Res; 2018 Dec; 34(4):133-139. PubMed ID: 30671098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease.
    Govaere O; Petersen SK; Martinez-Lopez N; Wouters J; Van Haele M; Mancina RM; Jamialahmadi O; Bilkei-Gorzo O; Lassen PB; Darlay R; Peltier J; Palmer JM; Younes R; Tiniakos D; Aithal GP; Allison M; Vacca M; Göransson M; Berlinguer-Palmini R; Clark JE; Drinnan MJ; Yki-Järvinen H; Dufour JF; Ekstedt M; Francque S; Petta S; Bugianesi E; Schattenberg JM; Day CP; Cordell HJ; Topal B; Clément K; Romeo S; Ratziu V; Roskams T; Daly AK; Anstee QM; Trost M; Härtlova A
    J Hepatol; 2022 May; 76(5):1001-1012. PubMed ID: 34942286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
    Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
    JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The complex function of macrophages and their subpopulations in metabolic injury associated fatty liver disease.
    Subramanian P; Chavakis T
    J Physiol; 2023 Apr; 601(7):1159-1171. PubMed ID: 36825510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism.
    Lefere S; Tacke F
    JHEP Rep; 2019 May; 1(1):30-43. PubMed ID: 32149275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioengineered Multicellular Liver Microtissues for Modeling Advanced Hepatic Fibrosis Driven Through Non-Alcoholic Fatty Liver Disease.
    Cho HJ; Kim HJ; Lee K; Lasli S; Ung A; Hoffman T; Nasiri R; Bandaru P; Ahadian S; Dokmeci MR; Lee J; Khademhosseini A
    Small; 2021 Apr; 17(14):e2007425. PubMed ID: 33690979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments.
    Kitade H; Chen G; Ni Y; Ota T
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis.
    Overi D; Carpino G; Franchitto A; Onori P; Gaudio E
    Cells; 2020 Mar; 9(3):. PubMed ID: 32131439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack.
    Oates JR; McKell MC; Moreno-Fernandez ME; Damen MSMA; Deepe GS; Qualls JE; Divanovic S
    Front Immunol; 2019; 10():2893. PubMed ID: 31921154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice.
    Ding J; Xu M; Du W; Fang ZQ; Xu H; Liu JJ; Song P; Xu C; Li ZW; Yue ZS; Ling YW; Duan JL; Tao KS; He F; Wang L
    Int J Biol Sci; 2023; 19(6):1941-1954. PubMed ID: 37063432
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Kazankov K; Jørgensen SMD; Thomsen KL; Møller HJ; Vilstrup H; George J; Schuppan D; Grønbæk H
    Nat Rev Gastroenterol Hepatol; 2019 Mar; 16(3):145-159. PubMed ID: 30482910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic Macrophage as a Key Player in Fatty Liver Disease.
    Xu L; Liu W; Bai F; Xu Y; Liang X; Ma C; Gao L
    Front Immunol; 2021; 12():708978. PubMed ID: 34956171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.